MABTHERA conc perf 100 mg/10 ml 2 flac 10 ml
7680543780176
CH-54378
L01FA01
07.16.1.
Reimbursement limitations:
MABTHERA.01
Hématologie:
Traitement de patients symptomatiques non prétraités avec lymphome non hodgkinien folliculaire CD20-positif (stades III-IV) …
1 / 3
google
Details
- Product number
- 5437801
- CPT
- -
- Packaging group
- 2
- Unit
- Durchstechflasche(n)
- Composition
- rituximabum 100 mg, natrii citras dihydricus, polysorbatum 80, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 52.6 mg.
Articles (1)
MabThera 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
52.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 518.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1998
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 54378
- Drug name
- MabThera, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/11/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MABTHERA conc perf 100 mg/10 ml 2 flac 10 ml
- Description (DE)
- MABTHERA Inf Konz 100 mg/10 ml 2 Durchstf 10 ml
- Market launch
- 27/11/1997
- Narcotic (BTM)
- No